Billionaire Ken Griffin Just Bought 7.9 Million Shares of This Beaten-Down Pharmaceutical Stock as It Eyes the Weight Loss Market
While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...
Novavax gets EU authorization for updated COVID vaccine targeting JN.1 strain
The authorization is for use in individuals 12 years of age and older. In August, the U.S. Food and Drug Administration ...
kffhealthnews48m
GSK’s Widely Used RSV Shot Retains 43% Potency In Third Year, Data Show
Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...
kffhealthnews18m
Insurers To Shift A Bit From Medicare Advantage To Special Needs Plans
Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or ...